Osteopontin is a novel downstream target of SOX9 with diagnostic implications for progression of liver fibrosis in humans.
Pritchett J, Harvey E, Athwal V, Berry A, Rowe C, Oakley F, Moles A, Mann DA, Bobola N, Sharrocks AD, Thomson BJ, Zaitoun AM, Irving WL, Guha IN, Hanley NA, Hanley KP.
Pritchett J, et al. Among authors: hanley kp, hanley na.
Hepatology. 2012 Sep;56(3):1108-16. doi: 10.1002/hep.25758.
Hepatology. 2012.
PMID: 22488688
Free PMC article.